ST-067 in Combination With CD19-Directed CAR T-Cell Therapy (Liso-cel) in Relapsed/Refractory Large B-Cell Lymphoma
Conditions
- Recurrent Diffuse Large B-Cell Lymphoma
- Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
- Recurrent Grade 3b Follicular Lymphoma
- Recurrent High-Grade B-Cell Lymphoma
- Recurrent Indolent B-Cell Non-Hodgkin Lymphoma
- Recurrent Primary Mediastinal Large B-Cell Lymphoma
- Refractory Diffuse Large B-Cell Lymphoma
- Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
- Refractory Grade 3b Follicular Lymphoma
- Refractory High-Grade B-Cell Lymphoma
- Refractory Indolent B-Cell Non-Hodgkin Lymphoma
- Refractory Primary Mediastinal Large B-Cell Lymphoma
Interventions
- BIOLOGICAL: Vevoctadekin
- PROCEDURE: Bone Marrow Aspiration
- PROCEDURE: Bone Marrow Biopsy
- PROCEDURE: Computed Tomography
- PROCEDURE: Echocardiography Test
- PROCEDURE: Leukapheresis
- BIOLOGICAL: Lisocabtagene Maraleucel
- PROCEDURE: Lumbar Puncture
- PROCEDURE: Lymphodepletion Therapy
- PROCEDURE: Multigated Acquisition Scan
- PROCEDURE: Positron Emission Tomography
- PROCEDURE: X-Ray Imaging
- PROCEDURE: Biospecimen Collection
Sponsor
Fred Hutchinson Cancer Center
Collaborators